Board meeting outcome for approval of Audited Financial results for the Quarter and year ended March 31, 2025

Revenue DeclinePat NegativeEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹584.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-2.8% vs market

Commodity Chemicals peers, median of 51sector+0.2%-1.8% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 1.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+1.3-2.8+0.2-1.8

Next day

-2.3+0.4-2.7-0.5-1.8

-1.2+0.3-1.5-0.7-0.5

-0.5+5.0-5.5+2.9-3.4

+0.9+6.7-5.7+3.0-2.1

-0.3+8.4-8.7+3.7-4.1

+2.8+10.3-7.5+4.8-1.9

15d

+1.9+12.8-10.9+4.8-2.9

+10.3+16.0-5.7+8.6+1.7

+21.2+16.9+4.3+8.0+13.2

+9.6+12.5-2.9+4.5+5.1

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 51Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of National Peroxide Ltd approved the audited financial results for the quarter and year ended March 31, 2025, along with the appointment of M/s. Parikh & Associates as Secretarial Auditor for FY2025-26 to FY2029-30, subject to shareholder approval. Statutory auditors Kalyaniwalla & Mistry LLP issued an unmodified (clean) opinion on the results. Full-year revenue from operations fell about 13.9% to ₹28,687.40 lakhs (FY24: ₹33,298.62 lakhs), and the company swung from a profit after tax of ₹1,679.03 lakhs in FY24 to a loss after tax of ₹(224.64) lakhs in FY25, translating to EPS of ₹(3.91) versus ₹29.22. Q4 FY25 alone posted a loss after tax of ₹(649.01) lakhs on revenue of ₹7,370.44 lakhs. Despite the bottom-line weakness, operating cash flow remained positive at ₹1,866.77 lakhs and borrowings declined to ₹351.76 lakhs.

Likely market impact

The sharp swing to a loss and declining top-line are negatives that may pressure the stock and weigh on near-term investor sentiment, though the clean audit, debt-free balance sheet and positive operating cash flow provide some cushion. Shareholders should watch upcoming quarters to see if the loss is structural or driven by one-off cost pressures in the single hydrogen-peroxide segment.